Italian Anderson Fabry Disease Cardiovascular Registry
Recruiting now
Conditions studied: Fabry Disease
In brief
The RICMAF Study is an observational, multicenter, non-pharmacological study conducted in Italy. Although Anderson-Fabry Disease (AFD) is rare, it is likely underdiagnosed due to its nonspecific symptoms, leading to delays in proper treatment. The RICMAF Study aims to improve understanding of AFD, especially its cardiac manifestations, which are a major cause of mortality. By gathering data from a large, nationwide patient registry, this study seeks to answer key questions about AFD's clinical course and improve patient outcomes. The primary goals of the RICMAF Study are: * To analyze the clinical profile, prevalence, and incidence of AFD, along with patients' family history and disease progression. * To identify early markers of cardiac involvement and predictors of cardiovascular complications to personalize care. * To investigate the relationship between genetic mutations, clinical presentation, and prognosis. * To find early indicators of organ damage through laboratory and imaging tests. All patients diagnosed with AFD following international guidelines are eligible.
Key facts
- Study ID
- NCT06806813
- Run by
- IRCCS Azienda Ospedaliero-Universitaria di Bologna
- People needed
- 800
- Starts
- 2022-01-26
- Expected to finish
- 2031-12-31
- Last updated by the study team
- 2025-02-04
Who can join
Age: 2 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patients diagnosed with Anderson Fabry disease
- Age ≥ 2 years at diagnosis
- Obtaining informed consent from the patient and parent or legal guardian.
You may not qualify if…
- None
Where it is running
- Policlinico Bari — Bari, Puglia/Bari, Italy (enrolling)
- AO Dei Colli - Ospedale Monaldi — Naples, Napoli, Italy (enrolling)
- Azienda Ospedaliero Universitaria Careggi e Meyer — Florence, Toscana/Firenze, Italy (enrolling)
- Molinette — Torino, Piemonte/Torino, Italy (enrolling)
- Fondazione Toscana Gabriele Monasterio — Pisa, Toscana/Pisa, Italy (enrolling)
- Arcispedale S.Maria Nuova — Reggio Emilia, Reggio Emilia, Italy (enrolling)
- Ospedale SS.ma Annunziata — Taranto, Puglia/Taranto, Italy (enrolling)
- Policlinico Rodolico — Catania, Sicilia/Catania, Italy (enrolling)
- Ospedale Padova — Padova, Veneto/Padova, Italy (enrolling)
- Centro Cardiologico Monzino — Milan, Lombardia/Milano, Italy (enrolling)
- Ospedale di Perugia — Perugia, Umbria/Perugia, Italy (enrolling)
- IRCCS Azienda Ospedaliero-Universitaria di Bologna — Bologna, EmiliaRomagna/Bologna, Italy (enrolling)
- Policlinico Gemelli — Roma, Roma, Italy (enrolling)
- A O Universitaria Ospedali Riuniti Ancona — Ancona, Marche/Ancona, Italy (enrolling)
- ASST Papa Giovanni XXIII — Bergamo, Lombardia/Bergamo, Italy (enrolling)
- IRCCS Policlinico San Donato — San Donato Milanese, Lombardia/Milano, Italy
- IRCCS Ospedale Policlinico San Martino — Genova, Genova, Italy
- Ospedale Koelliker di Torino — Torino, Piemonte/Torino, Italy
- Ospedale Niguarda — Milan, Lombardia/Milano, Italy
- AORN "Sant'Anna e San Sebastiano" di Caserta — Caserta, Caserta, Italy
- Ospedale Maggiore della Carità — Novara, Piemonte/Novara, Italy
- IRCCS San Gerardo dei Tintori - S.C. Nefrologia, Monza - Università di Milano Bicocca — Milan, Lombardia/Milano, Italy
- Ospedale Ivrea — Ivrea, Piemonte/Ivrea, Italy
- Azienda Ospedaliera "Guglielmo da Saliceto" di Piacenza — Piacenza, Piacenza, Italy
- IRCCS Ospedale Maggiore Policlinico di Milano — Milan, Lombardia/Milano, Italy
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.